Immunotherapy Combination Studies Need Rational Path Considering Patient Population

Immunotherapy Combination Studies Need Rational Path Considering Patient Population

User Photo
AnnualMeeting-SITC2017

3 years
462 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Lawrence Fong, MD of University of California, San Francisco explains how there are several combination therapies to study, but not enough patient-participants for these clinical trials. He hopes for a more rational path regarding patients in order to see which combination therapies will work. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Up Next Autoplay
User Photo